Kinaxis (TSE:KXS - Get Free Report) received a C$210.00 price target from research analysts at Royal Bank Of Canada in a report released on Wednesday,BayStreet.CA reports. The firm currently has an "outperform" rating on the stock. Royal Bank Of Canada's price objective would suggest a potential upside of 21.63% from the stock's current price.
Several other equities analysts also recently weighed in on the company. Stifel Nicolaus dropped their target price on Kinaxis from C$245.00 to C$200.00 and set a "buy" rating for the company in a research report on Wednesday, May 6th. BMO Capital Markets increased their price target on shares of Kinaxis from C$195.00 to C$200.00 and gave the stock an "outperform" rating in a research report on Friday, August 7th. Canadian Imperial Bank of Commerce raised their price objective on shares of Kinaxis from C$173.00 to C$205.00 in a research note on Friday, June 5th. Finally, National Bank Financial upped their target price on shares of Kinaxis from C$200.00 to C$210.00 and gave the stock an "outperform" rating in a research note on Friday, August 7th. Seven investment analysts have rated the stock with a Buy rating, According to data from MarketBeat, the company currently has a consensus rating of "Buy" and a consensus price target of C$203.12.
View Our Latest Analysis on Kinaxis
Kinaxis Trading Down 1.6%
Shares of TSE:KXS traded down C$2.85 during mid-day trading on Wednesday, reaching C$172.66. 68,620 shares of the company were exchanged, compared to its average volume of 120,421. Kinaxis has a 1 year low of C$117.22 and a 1 year high of C$192.14. The company has a debt-to-equity ratio of 11.14, a current ratio of 1.88 and a quick ratio of 2.29. The firm's 50-day simple moving average is C$160.57 and its 200 day simple moving average is C$147.88. The firm has a market cap of C$4.69 billion, a price-to-earnings ratio of 56.42, a P/E/G ratio of 3.60 and a beta of 0.76.
Kinaxis (TSE:KXS - Get Free Report) last announced its earnings results on Wednesday, August 5th. The company reported C$1.08 earnings per share (EPS) for the quarter. Kinaxis had a return on equity of 20.88% and a net margin of 14.40%.The company had revenue of C$230.64 million for the quarter. Equities research analysts forecast that Kinaxis will post 4.2526231 EPS for the current year.
Insider Buying and Selling
In other news, insider Andrew William Robert Bell sold 3,000 shares of Kinaxis stock in a transaction dated Friday, August 21st. The stock was sold at an average price of C$179.48, for a total value of C$538,440.00. Following the completion of the transaction, the insider owned 1,455 shares in the company, valued at approximately C$261,143.40. This trade represents a 67.34% decrease in their position. Also, insider Mark Justin Morgan sold 3,000 shares of the business's stock in a transaction dated Tuesday, August 11th. The stock was sold at an average price of C$172.25, for a total value of C$516,750.00. Following the transaction, the insider directly owned 10,299 shares of the company's stock, valued at approximately C$1,774,002.75. This represents a 22.56% decrease in their ownership of the stock. Insiders have sold 34,026 shares of company stock worth $5,795,539 over the last ninety days. Company insiders own 1.20% of the company's stock.
Kinaxis Company Profile
(
Get Free Report)
Kinaxis is a leader in modern supply chain orchestration, powering complex global supply chains, and supporting the people who manage them. Our powerful, AI-infused supply chain orchestration platform, Maestro, combines proprietary technologies and techniques that provide full transparency and agility across the entire supply chain - from multi-year strategic planning to last-mile delivery. We are trusted by renowned global brands to provide the agility and predictability needed to navigate today's volatility and disruption.
Featured Articles

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Before you consider Kinaxis, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Kinaxis wasn't on the list.
While Kinaxis currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.